Selecta Biosciences, Inc.
NASDAQ:SELB
0.8812 (USD) • At close November 13, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 110.777 | 85.077 | 16.597 | 6.677 | 0.903 | 0.207 | 8.083 | 6.011 | 3.04 |
| Cost of Revenue
| 0 | 72.377 | 68.736 | 54.505 | 42.743 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 0 | 38.4 | 16.341 | -37.908 | -36.066 | 0.903 | 0.207 | 8.083 | 6.011 | 3.04 |
| Gross Profit Ratio
| 0 | 0.347 | 0.192 | -2.284 | -5.402 | 1 | 1 | 1 | 1 | 1 |
| Reseach & Development Expenses
| 71.839 | 72.377 | 68.736 | 54.505 | 42.743 | 47.687 | 45.165 | 29.702 | 22.98 | 10.486 |
| General & Administrative Expenses
| 40.581 | 23.862 | 20.938 | 18.913 | 16.389 | 18.238 | 18.826 | 13.051 | 8.335 | 7.953 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 40.581 | 23.862 | 20.938 | 18.913 | 16.389 | 18.238 | 18.826 | 13.051 | 8.335 | 7.953 |
| Other Expenses
| 0 | 0.33 | 0.015 | 0.089 | -1.306 | 0.01 | -0.152 | 0.004 | -0.026 | -0.044 |
| Operating Expenses
| 112.42 | 96.239 | 89.674 | 73.418 | 59.132 | 65.925 | 63.991 | 42.753 | 31.315 | 18.439 |
| Operating Income
| -86.416 | 14.538 | -4.597 | -56.821 | -52.455 | -65.022 | -63.784 | -34.67 | -25.304 | -15.399 |
| Operating Income Ratio
| 0 | 0.131 | -0.054 | -3.424 | -7.856 | -72.007 | -308.135 | -4.289 | -4.21 | -5.065 |
| Total Other Income Expenses Net
| -152.294 | 20.232 | -5.124 | -12.055 | -2.895 | 1.18 | -0.331 | -0.287 | 1.078 | 3.071 |
| Income Before Tax
| -238.71 | 34.77 | -9.721 | -68.876 | -55.35 | -65.336 | -65.321 | -36.21 | -25.174 | -12.88 |
| Income Before Tax Ratio
| 0 | 0.314 | -0.114 | -4.15 | -8.29 | -72.354 | -315.56 | -4.48 | -4.188 | -4.237 |
| Income Tax Expense
| 19 | -0.609 | 15.966 | 0.911 | -1.814 | 1.18 | 0.304 | 0.455 | 0.922 | 0.508 |
| Net Income
| -219.71 | 35.379 | -25.687 | -69.787 | -53.536 | -65.336 | -65.321 | -36.21 | -25.174 | -12.88 |
| Net Income Ratio
| 0 | 0.319 | -0.302 | -4.205 | -8.018 | -72.354 | -315.56 | -4.48 | -4.188 | -4.237 |
| EPS
| -0.001 | 0.24 | -0.22 | -0.69 | -1.18 | -2.92 | -3.2 | -3.45 | -1.96 | -1 |
| EPS Diluted
| -0.001 | 0.1 | -0.22 | -0.69 | -1.18 | -2.92 | -3.2 | -3.45 | -1.96 | -1 |
| EBITDA
| -86.416 | 16.155 | -4.582 | -56.732 | -53.761 | -65.012 | -63.936 | -34.666 | -24.286 | -14.579 |
| EBITDA Ratio
| 0 | 0.146 | -0.054 | -3.418 | -8.052 | -71.996 | -308.87 | -4.289 | -4.04 | -4.796 |